The Alzheimer's vaccine will be ready within 5 years. A good result, for a disease that scares many people. The development of a vaccine against Alzheimer's could be a question for years now, as emerges from a study of Adelaide Flinders University, in Australia, published in the magazine Nature. By 2018 they will be the first tests were carried out on man.
And it doesn't end here. Alzheimer's disease in the future could be diagnosed early, with ad hoc tests, perhaps a blood sample or a urine test to be carried out around the age of 40. AND thanks to preventive therapies, for example antibodies and vaccines, it will be possible to block the disease well before of the onset of symptoms.
Alzheimer's is the most common form of dementia, strikes the world today 25 million individuals, and it is scary precisely because it erases who we are and who we have been.
«Today – says Patrizia Mecocci of the University of Perugia – to “diagnose” a potential risk of Alzheimer's we have the available tomography and peptide-specific tracer beta-amyloid, PET-amyloid which highlights accumulations of the toxic peptide in the brain. But it is an expensive test that is reserved for a few subjects, possibly to be involved in clinical trials."
